Malignant oral melanoma clinical study (dogs).

Study details.

This is a randomized, blinded, placebo-controlled trial of approximately 182 days in duration. Dogs will be randomly assigned to receive a novel immunotherapy or a placebo (non-active saline).

Inclusion criteria:

Exclusion criteria:

Locations and contacts:

Covered costs.

The costs of all diagnostics and procedures required for the study are covered by the sponsor.